Microvascular Disease Diagnosis: From PET-CT to Invasive Coronary Flow Assessment
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Bracco Diagnostics; CDL Nuclear Technologies</li><li>Grant Support/Research Contract - Shockwave Medical; Powerful Medical</li></ul>